Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort
; M R Abern (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 4, 2016 Category: Urology & Nephrology Authors: H Wadhwa M K Terris W J Aronson C J Kane C L Amling M R Cooperberg S J Freedland M R Abern Source Type: research

A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
u & J Jin (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 27, 2016 Category: Urology & Nephrology Authors: C Jin Y Fan Y Meng C Shen Y Wang S Hu C Cui T Xu W Yu J Jin Source Type: research

Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer
De Bono (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 27, 2016 Category: Urology & Nephrology Authors: G Sonpavde G R Pond A J Templeton E D Kwon J S De Bono Source Type: research

Role of OATP transporters in steroid uptake by prostate cancer cells in vivo
A Mostaghel (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 20, 2016 Category: Urology & Nephrology Authors: S M Green A Kaipainen K Bullock A Zhang J M Lucas C Matson W A Banks E A Mostaghel Source Type: research

Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study
amp; J Huber (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 13, 2016 Category: Urology & Nephrology Authors: B Hager K Kraywinkel B Keck A Katalinic M Meyer S R Zeissig R Scheufele M P Wirth J Huber Source Type: research

The very-high-risk prostate cancer: a contemporary update
owitch (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 13, 2016 Category: Urology & Nephrology Authors: R Mano J Eastham O Yossepowitch Source Type: research

Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project
; S E Steck (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 6, 2016 Category: Urology & Nephrology Authors: E H Allott L Arab L J Su L Farnan E T H Fontham J L Mohler J T Bensen S E Steck Source Type: research

A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
u & J Jin (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 6, 2016 Category: Urology & Nephrology Authors: C Jin Y Fan Y Meng C Shen Y Wang S Hu C Cui T Xu W Yu J Jin Source Type: research

Decipher correlation patterns post prostatectomy: initial experience from 2  342 prospective patients
Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients Prostate Cancer and Prostatic Diseases advance online publication, August 30 2016. doi:10.1038/pcan.2016.38 Authors: R B Den, M Santiago-Jimenez, J Alter, M Schliekelman, J R Wagner, J F Renzulli II, D I Lee, C G Brito, K Monahan, B Gburek, N Kella, G Vallabhan, F Abdollah, E J Trabulsi, C D Lallas, L G Gomella, T L Woodlief, Z Haddad, L L C Lam, S Deheshi, Q Wang, V Choeurng, M du Plessis, J Jordan, B Parks, H Shin, C Buerki, K Yousefi, E Davicioni, V R Patel & N L Shah (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 30, 2016 Category: Urology & Nephrology Authors: R B Den M Santiago-Jimenez J Alter M Schliekelman J R Wagner J F Renzulli II D I Lee C G Brito K Monahan B Gburek N Kella G Vallabhan F Abdollah E J Trabulsi C D Lallas L G Gomella T L Woodlief Z Haddad L L C Lam S Deheshi Q Wang V Choeurng M du Plessis J Source Type: research

Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013
J Huber (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 23, 2016 Category: Urology & Nephrology Authors: C Groeben R Koch M Baunacke M P Wirth J Huber Source Type: research

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005 –2013: a population-based analysis
Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis Prostate Cancer and Prostatic Diseases advance online publication, August 16 2016. doi:10.1038/pcan.2016.36 Authors: K Lahdensuo, A Rannikko, V-J Anttila, A Erickson, A Pätäri-Sampo, M Rautio, H Santti, E Tarkka, M Vaara & K Huotari (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 16, 2016 Category: Urology & Nephrology Authors: K Lahdensuo A Rannikko V-J Anttila A Erickson A P ätäri-Sampo M Rautio H Santti E Tarkka M Vaara K Huotari Source Type: research

The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial
amp; H U Ahmed (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 9, 2016 Category: Urology & Nephrology Authors: A El-Shater Bosaily M Valerio Y Hu A Freeman C Jameson L Brown R Kaplan R G Hindley D Barratt M Emberton H U Ahmed Source Type: research

Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95  577 cases from a nationwide German health insurance database
Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database Prostate Cancer and Prostatic Diseases advance online publication, August 9 2016. doi:10.1038/pcan.2016.33 Authors: C Gilfrich, H Leicht, C Fahlenbrach, E Jeschke, G Popken, J U Stolzenburg, L Weißbach, C Zastrow & C Günster (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 9, 2016 Category: Urology & Nephrology Authors: C Gilfrich H Leicht C Fahlenbrach E Jeschke G Popken J U Stolzenburg L Wei ßbach C Zastrow C G ünster Source Type: research

Tumor features and survival after radical prostatectomy among antidiabetic drug users
Murtola (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 9, 2016 Category: Urology & Nephrology Authors: R M Joentausta P M Kujala T Visakorpi T L J Tammela T J Murtola Source Type: research

Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer
-E Taplin (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 9, 2016 Category: Urology & Nephrology Authors: R R McKay L Werner M Fiorillo M Nakabayashi P W Kantoff M-E Taplin Source Type: research

Increasing incidence of metastatic prostate cancer in the United States (2004 –2013)
Increasing incidence of metastatic prostate cancer in the United States (2004–2013) Prostate Cancer and Prostatic Diseases advance online publication, July 19 2016. doi:10.1038/pcan.2016.30 Authors: A B Weiner, R S Matulewicz, S E Eggener & E M Schaeffer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 19, 2016 Category: Urology & Nephrology Authors: A B Weiner R S Matulewicz S E Eggener E M Schaeffer Source Type: research

Increasing incidence of metastatic prostate cancer in the United States (2004–2013)
Increasing incidence of metastatic prostate cancer in the United States (2004–2013) Prostate Cancer and Prostatic Diseases advance online publication, July 19 2016. doi:10.1038/pcan.2016.30 Authors: A B Weiner, R S Matulewicz, S E Eggener & E M Schaeffer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 19, 2016 Category: Urology & Nephrology Authors: A B WeinerR S MatulewiczS E EggenerE M Schaeffer Source Type: research

Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis
ng & H Y Zhang (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 19, 2016 Category: Urology & Nephrology Authors: Y ZhaoJ J LvJ ChenX B JinM W WangZ H SuL Y WangH Y Zhang Source Type: research

A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment
L Wright, D W Lin & I M Thompson (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 19, 2016 Category: Urology & Nephrology Authors: M A LissJ M SchenkA V FainoL F NewcombH BoyerJ D BrooksP R CarrollA DashM D FabrizioM E GleaveP S NelsonM L NeuhouserJ T WeiY ZhengJ L WrightD W LinI M Thompson Source Type: research

Can nomograms improve our ability to select candidates for active surveillance for prostate cancer?
; S Punnen (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 19, 2016 Category: Urology & Nephrology Authors: V IremashviliM ManoharanD J ParekhS Punnen Source Type: research

PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure
M Emberton & H U Ahmed (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 19, 2016 Category: Urology & Nephrology Authors: T T ShahM PetersA KanthabalanN McCartanY FatolaJ van der Voort van ZypM van VulpenA FreemanC M MooreM AryaM EmbertonH U Ahmed Source Type: research

Impact of the extent of extraprostatic extension defined by Epstein ’s method in patients with negative surgical margins and negative lymph node invasion
Impact of the extent of extraprostatic extension defined by Epstein’s method in patients with negative surgical margins and negative lymph node invasion Prostate Cancer and Prostatic Diseases advance online publication, July 12 2016. doi:10.1038/pcan.2016.24 Authors: T Maubon, N Branger, C Bastide, G Lonjon, K-A Harvey-Bryan, P Validire, S Giusiano, D Rossi, X Cathelineau & F Rozet (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 12, 2016 Category: Urology & Nephrology Authors: T Maubon N Branger C Bastide G Lonjon K-A Harvey-Bryan P Validire S Giusiano D Rossi X Cathelineau F Rozet Source Type: research

The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial
Emberton & H U Ahmed (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 12, 2016 Category: Urology & Nephrology Authors: A El-Shater BosailyM ValerioY HuA FreemanC JamesonL BrownR KaplanR G HindleyD BarrattM EmbertonH U Ahmed Source Type: research

Impact of the extent of extraprostatic extension defined by Epstein’s method in patients with negative surgical margins and negative lymph node invasion
Impact of the extent of extraprostatic extension defined by Epstein’s method in patients with negative surgical margins and negative lymph node invasion Prostate Cancer and Prostatic Diseases advance online publication, July 12 2016. doi:10.1038/pcan.2016.24 Authors: T Maubon, N Branger, C Bastide, G Lonjon, K-A Harvey-Bryan, P Validire, S Giusiano, D Rossi, X Cathelineau & F Rozet (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 12, 2016 Category: Urology & Nephrology Authors: T MaubonN BrangerC BastideG LonjonK-A Harvey-BryanP ValidireS GiusianoD RossiX CathelineauF Rozet Source Type: research

Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
ma & S J Freedland (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 5, 2016 Category: Urology & Nephrology Authors: L E HowardA M De HoedtW J AronsonC J KaneC L AmlingM R CooperbergM K TerrisC H DiversA ValderramaS J Freedland Source Type: research

A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients
li-Conwright (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 28, 2016 Category: Urology & Nephrology Authors: J L KiwataT B DorffE T SchroederM E GrossC M Dieli-Conwright Source Type: research

The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts
V Venkateswaran (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 28, 2016 Category: Urology & Nephrology Authors: A D VandersluisD E GuyL H KlotzN E FleshnerA KissC ParkerV Venkateswaran Source Type: research

Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells
i & S Sharma (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 28, 2016 Category: Urology & Nephrology Authors: S GuptaA WestonJ BearrsT ThodeA NeissR SoldiS Sharma Source Type: research

Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer
J Hong & Y D Choi (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 28, 2016 Category: Urology & Nephrology Authors: W S JangK S ChoK H KimC Y YoonY J KangJ Y LeeW S HamK H RhaS J HongY D Choi Source Type: research

The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
amp; I Díaz-Laviada (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 21, 2016 Category: Urology & Nephrology Authors: C MorellA BortD VaraA Ramos-TorresN Rodríguez-HencheI Díaz-Laviada Source Type: research

Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up
, R Mehra, T M Morgan & F Y Feng (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 24, 2016 Category: Urology & Nephrology Authors: D E SprattW C JacksonA AbugharibS A TomlinsR T DessP D SoniJ Y LeeS G ZhaoA I ColeZ S ZumstegH SandlerD HamstraJ W HearnG PalapattuR MehraT M MorganF Y Feng Source Type: research

Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
amp; J Luo (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 17, 2016 Category: Urology & Nephrology Authors: E S AntonarakisA J ArmstrongS M DehmJ Luo Source Type: research

Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance
henfellner & B A Hadaschik (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 17, 2016 Category: Urology & Nephrology Authors: J P RadtkeT H KuruD BonekampM T FreitagM B WolfC D AltG HatibogluS BoxlerS PahernikW RothM C RoethkeH P SchlemmerM HohenfellnerB A Hadaschik Source Type: research

MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor
leischmann (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 10, 2016 Category: Urology & Nephrology Authors: V GenitschI ZlobecG N ThalmannA Fleischmann Source Type: research

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of > 1000 prostatectomies
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of>1000 prostatectomies Prostate Cancer and Prostatic Diseases advance online publication, May 3 2016. doi:10.1038/pcan.2016.12 Authors: M S Tretiakova, W Wei, H D Boyer, L F Newcomb, S Hawley, H Auman, F Vakar-Lopez, J K McKenney, L Fazli, J Simko, D A Troyer, A Hurtado-Coll, I M Thompson, P R Carroll, W J Ellis, M E Gleave, P S Nelson, D W Lin, L D True, Z Feng & J D Brooks (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 3, 2016 Category: Urology & Nephrology Authors: M S Tretiakova W Wei H D Boyer L F Newcomb S Hawley H Auman F Vakar-Lopez J K McKenney L Fazli J Simko D A Troyer A Hurtado-Coll I M Thompson P R Carroll W J Ellis M E Gleave P S Nelson D W Lin L D True Z Feng J D Brooks Source Type: research

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
Freedland, R J Karnes & E M Schaeffer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 3, 2016 Category: Urology & Nephrology Authors: A E RossR B DenK YousefiB J TrockJ TosoianE DavicioniD J S ThompsonV ChoeurngZ HaddadP T TranE J TrabulsiL G GomellaC D LallasF AbdollahF Y FengE A KleinA P DickerS J FreedlandR J KarnesE M Schaeffer Source Type: research

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
Ross & S Y Cho (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 3, 2016 Category: Urology & Nephrology Authors: S P RoweM A GorinM E AllafK J PientaP T TranM G PomperA E RossS Y Cho Source Type: research

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of>1000 prostatectomies Prostate Cancer and Prostatic Diseases advance online publication, May 3 2016. doi:10.1038/pcan.2016.12 Authors: M S Tretiakova, W Wei, H D Boyer, L F Newcomb, S Hawley, H Auman, F Vakar-Lopez, J K McKenney, L Fazli, J Simko, D A Troyer, A Hurtado-Coll, I M Thompson, P R Carroll, W J Ellis, M E Gleave, P S Nelson, D W Lin, L D True, Z Feng & J D Brooks (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 3, 2016 Category: Urology & Nephrology Authors: M S TretiakovaW WeiH D BoyerL F NewcombS HawleyH AumanF Vakar-LopezJ K McKenneyL FazliJ SimkoD A TroyerA Hurtado-CollI M ThompsonP R CarrollW J EllisM E GleaveP S NelsonD W LinL D TrueZ FengJ D Brooks Source Type: research

Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease
& M J Zelefsky (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 26, 2016 Category: Urology & Nephrology Authors: D E SprattJ R OsborneZ S ZumstegK RebeizJ LeemanA RiveraM J MorrisM J Zelefsky Source Type: research

Chemotherapy for metastatic castrate-sensitive prostate cancer
weeney (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 15, 2016 Category: Urology & Nephrology Authors: R E MillerC J Sweeney Source Type: research

Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy
Montie & M L Cher (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2016 Category: Urology & Nephrology Authors: T M MorganS R HawkenK R GhaniD C MillerF Y FengS M LinsellJ A SaliszY GaoJ E MontieM L Cher Source Type: research

Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy
hoskes (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2016 Category: Urology & Nephrology Authors: A S PolackwichD A Shoskes Source Type: research

Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy
u, B Dong, W Xue & Y Huang (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2016 Category: Urology & Nephrology Authors: Y WangW YinZ WangJ HuangJ PanY ZhuF XuX ShaoJ ShaY CaiQ LiuB DongW XueY Huang Source Type: research

Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE
amp; S J Freedland (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 1, 2016 Category: Urology & Nephrology Authors: S FischerS SunL E HowardD M MoreiraR Castro-SantamariaG L AndrioleA C VidalS J Freedland Source Type: research

Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment
A Mucci & I M Shui (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 1, 2016 Category: Urology & Nephrology Authors: A SanchezJ D SchoenfeldP L NguyenM FiorentinoD ChowdhuryM J StampferH D SessoE GiovannucciL A MucciI M Shui Source Type: research

Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis
M W Salkini (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 9, 2016 Category: Urology & Nephrology Authors: A D RavalD ThakkerH NegiA VyasM W Salkini Source Type: research

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism
Tatsugami & M Eto (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 9, 2016 Category: Urology & Nephrology Authors: M ShiotaN FujimotoA YokomizoA TakeuchiE KashiwagiT DejimaK KiyoshimaJ InokuchiK TatsugamiM Eto Source Type: research

Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy
F Montorsi & A Briganti (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 9, 2016 Category: Urology & Nephrology Authors: G GandagliaG ListaN FossatiN SuardiA GallinaM MoschiniL BianchiM S RossiR SchiavinaS F ShariatA SaloniaF MontorsiA Briganti Source Type: research

Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science
& T B Dorff (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 2, 2016 Category: Urology & Nephrology Authors: N NussbaumD J GeorgeA P AbernethyC M DolanN OestreicherS FlandersT B Dorff Source Type: research

The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy
riganti, D S Scherr & S F Shariat (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 26, 2016 Category: Urology & Nephrology Authors: S SevcencoR MathieuP BaltzerT KlatteH FajkovicC SeitzP I KarakiewiczM RouprêtM RinkL KluthQ-D TrinhW LoidlA BrigantiD S ScherrS F Shariat Source Type: research